Trial Profile
Efficacy and toxicity of gefitinib in palliative treatment in recurrent squamous cell carcinoma of head and neck in poor performance elderly patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 21 Sep 2015 New trial record